BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1018 related articles for article (PubMed ID: 17499419)

  • 1. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study.
    Caglar GS; Tasci Y; Kayikcioglu F; Haberal A
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):227-31. PubMed ID: 17499419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
    Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.
    Dryden PJ; O'Connor JP; Jamieson WR; Reid I; Ansley D; Sadeghi H; Burr LH; Munro AI; Merrick PM
    Can J Anaesth; 1997 Sep; 44(9):934-41. PubMed ID: 9305556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative tranexamic acid to decrease blood loss during myomectomy: a randomized, double-blind, placebo-controlled trial.
    Opoku-Anane J; Vargas MV; Marfori CQ; Moawad G; Maasen MS; Robinson JK
    Am J Obstet Gynecol; 2020 Sep; 223(3):413.e1-413.e7. PubMed ID: 32229194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tranexamic acid on blood loss during orthognathic surgery: a randomized controlled trial.
    Choi WS; Irwin MG; Samman N
    J Oral Maxillofac Surg; 2009 Jan; 67(1):125-33. PubMed ID: 19070758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty].
    Zhang F; Gao Z; Yu J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Dec; 21(12):1302-4. PubMed ID: 18277670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    Gungorduk K; Yıldırım G; Asıcıoğlu O; Gungorduk OC; Sudolmus S; Ark C
    Am J Perinatol; 2011 Mar; 28(3):233-40. PubMed ID: 20979013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic Acid reduces perioperative blood loss in adult patients having spinal fusion surgery.
    Wong J; El Beheiry H; Rampersaud YR; Lewis S; Ahn H; De Silva Y; Abrishami A; Baig N; McBroom RJ; Chung F
    Anesth Analg; 2008 Nov; 107(5):1479-86. PubMed ID: 18931202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied.
    Alvarez JC; Santiveri FX; Ramos I; Vela E; Puig L; Escolano F
    Transfusion; 2008 Mar; 48(3):519-25. PubMed ID: 18067499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ; Nielsen C
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of topical tranexamic acid in open heart surgery.
    Abul-Azm A; Abdullah KM
    Eur J Anaesthesiol; 2006 May; 23(5):380-4. PubMed ID: 16438759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
    Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Tranexamic Acid on Myomectomy-Associated Blood Loss in Patients With Multiple Myomas: A Randomized Controlled Clinical Trial.
    Shaaban MM; Ahmed MR; Farhan RE; Dardeer HH
    Reprod Sci; 2016 Jul; 23(7):908-12. PubMed ID: 26718305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid as a means of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease.
    Vacharaksa K; Prakanrattana U; Suksompong S; Chumpathong S
    J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S904-9. PubMed ID: 12452228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.